Filter Results


Study status

(for at least one location)



Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 18 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants

    Rochester, MN

  2. A Study to Evaluate GB002 in Adults with Pulmonary Arterial Hypertension (PAH)

    Jacksonville, FL, Rochester, MN

  3. A Study to Assess the Aria CV Pulmonary Hypertension System to Treat Pulmonary Arterial Hypertension

    Rochester, MN

  4. An Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan to Treat Patients with Pulmonary Arterial Hypertension

    Scottsdale/Phoenix, AZ

  5. A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (ELEVATE 2)

    Jacksonville, FL, Rochester, MN

  6. A Study to Evaluate the Safety and Effectiveness of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)

    Jacksonville, FL

  7. A Study to Evaluate the Effectiveness and Safety of RalinEpag for Improving Treatment Outcomes in PAH Patients

    Jacksonville, FL

  8. Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension

    Rochester, MN

  9. A Study to Evaluate the Effectiveness and Safety of Remdesivir to Treat Coronavirus Disease 2019 in an Outpatient Setting

    Rochester, MN

  10. Pulmonary Hypertension and Chronic Kidney Disease

    Rochester, MN


Mayo Clinic Footer